Chester County News and Community Website
Recro (Nasdaq: REPH), headquartered in Malvern, PA, is a contract development and manufacturing organization, or CDMO, with integrated solutions for formulation, analytical services, regulatory support, manufacturing and packaging of both commercial and development stage oral solid dose drug products. For more information see www.recrocdmo.com.
EXTON, PA — Recro Pharma, Inc. (NASDAQ: REPH) announced the recent expansion of its team through the addition of new employees to support product development, business development, quality, technical operations, …
Read More EXTON, PA — Recro Pharma, Inc. (NASDAQ: REPH) announced this week’s signing of a renewable energy agreement with Georgia Power under which the company will purchase 1.2 million renewable energy …
Read More EXTON, PA — Recro Pharma, Inc. (“Recro”; NASDAQ: REPH) recently announced its acquisition of IRISYS, a San Diego-based CDMO that possesses capabilities that complement and expand those of Recro.
Read More EXTON, PA — Recro Pharma, Inc. (NASDAQ: REPH) this week announced that it has signed a non-binding letter of intent for its acquisition of a full-service CDMO with capabilities that …
Read More EXTON, PA — Recro Pharma, Inc. (NASDAQ: REPH) recently reported financial results for the second quarter and six months ended June 30, 2021.
Read More EXTON, PA — Recro Pharma, Inc. (: REPH) announced that the company will release financial results for the second quarter 2021 after the market close on Monday, August 9, 2021. …
Read More EXTON, PA — Recro Pharma, Inc. (NASDAQ: REPH) announced the appointment of Erica Raether as the company’s inaugural vice president of people, culture and ESG (environmental, social and governance). Ms. …
Read More EXTON, PA — Recro Pharma, Inc. (NASDAQ: REPH) announced the expansion of its team through the addition of new employees to support business development, technical operations and certain strategic initiatives.
Read More EXTON, PA — Recro Pharma, Inc. (NASDAQ: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges for companies developing oral solid dose drug …
Read More EXTON, PA — Recro Pharma, Inc. (NASDAQ: REPH) announced the signing of a new development agreement with Astex Pharmaceuticals, Inc.
Read More